This Seminar is presented by Rebecca Cypher, MSN, PNNP, 2019 AWHONN President-Elect and nationally respected expert in EFM. This seminar helps prepare the participant for NCC RNC EFM or Perinatal Quality Foundation FM Credentialing Exams.
This seminar includes essential content to validate your core EFM knowledge with vital updates in research. NICHD, AWHONN, ACOG and ACNM fetal monitoring standards and guidelines are presented. An on site paper-pencil NCC EFM examination is available to those who have applied for, and been accepted as an eligible candidate, of the EFM subspecialty exam.
Note: Taking the review course does not guarantee passing the exam.
Rebecca is a nationally respected leader and consultant in perinatal healthcare. She brings to the program over 30 years of active duty Air Force and civilian nursing experience. Her career consisted of a number of diverse professional roles, including direct patient care, management, education and research. She is nationally certiﬁed in Inpatient OB and EFM. An active member of AWHONN, she is currently the 2019 President Elect. Previously she served in a variety of AWHONN positions including two terms on the Board of Directors. Rebecca joined Lisa Miller, CNM, JD, and Dr. David Miller as co-author for Mosby’s Fetal Monitoring: A Multidisciplinary Approach (8th ed.) and has been a contributor to AWHONN’s Fetal Monitoring Principles and Practices (5th ed). She has authored numerous book chapters and manuscripts published in a number of leading nursing and medical references. Currently, she is a reviewer for Nursing for Women’s Health, on the editorial board for the Journal of Perinatal and Neonatal Nursing, and a Contributing Editor for the Legal Issues and Risk Management column. Committed to improving quality and safety in perinatal care, balanced with thoughtful insight in a simple but comprehensive teaching style, Rebecca will share a wealth of knowledge and up to date evidence, based on her extensive clinical experience and education.
Professional Education Center (PEC) is a provider approved by the California Board of Registered Nursing, Provider #9890, Florida FBN #2219 for 11.5 (7.5 Day 1 and 4.5 Day 2) Contact Hours. Meets Texas Type I criteria.
Neither program planners or presenters have any commercial conflict of interest
PROFESSIONAL EDUCATION CENTER is dedicated to bringing you the most respected speakers, and providing education that is clinically essential. Education that you will use every day – Education that makes a difference! The opportunity to share experiences and network with your peers is just one more reason to choose Professional Education Center for your CE programs!
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.